Products
Paclitaxel promotes microtubule polymerization and stabilizes polymerized microtubules, a unique mechanism among known drugs.
It specifically binds to polymerized microtubules without affecting unpolymerized tubulin dimers.
Paclitaxel interferes with cellular functions by causing microtubule accumulation, effectively blocking cell division during mitosis.
Clinically effective for ovarian and breast cancer, with additional therapeutic effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
Product Description
Products Description of Paclitaxel CAS#33069-62-4
Paclitaxel is a diterpene extracted from yew bark. It uniquely promotes and stabilizes microtubule polymerization, binding only to formed microtubules. It disrupts cell division and arrests mitosis. Clinically, it is mainly used for ovarian and breast cancers, and also effective against lung, colorectal, melanoma, lymphoma and other malignancies.
Product Application of Paclitaxel CAS#33069-62-4
Paclitaxel is a natural broad-spectrum anticancer drug mainly for metastatic breast and ovarian cancers. It binds β-tubulin to stabilize microtubules, block depolymerization and arrest cell cycle at G2/M phase to suppress mitosis. It also acts effectively on human endothelial cells with low IC50 value.
Product Information
Parameters
Safety Information
Factory Showcase
Loading and Transport
Product Inquiry
Related Products
Send Us Your Inquiry Today

Whether you have inquiries about product specifications, pricing, delivery, or customized solutions, please leave us a detailed message. Our professional sales and technical team will respond to you promptly and provide one-stop support for your global procurement.